| Product Code: ETC10083019 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam RNAI Therapeutics Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam RNAI Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam RNAI Therapeutics Market - Industry Life Cycle |
3.4 Vietnam RNAI Therapeutics Market - Porter's Five Forces |
3.5 Vietnam RNAI Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Vietnam RNAI Therapeutics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Vietnam RNAI Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Vietnam |
4.2.2 Rising investments in research and development of RNAi therapeutics |
4.2.3 Growing awareness and acceptance of RNAi technology in the medical community |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals in RNAi therapeutics |
4.3.2 Stringent regulatory requirements for approval of RNAi therapeutics in Vietnam |
4.3.3 High costs associated with development and commercialization of RNAi therapeutics |
5 Vietnam RNAI Therapeutics Market Trends |
6 Vietnam RNAI Therapeutics Market, By Types |
6.1 Vietnam RNAI Therapeutics Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Vietnam RNAI Therapeutics Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Vietnam RNAI Therapeutics Market Revenues & Volume, By Intradermal Injections, 2021- 2031F |
6.1.4 Vietnam RNAI Therapeutics Market Revenues & Volume, By Pulmonary Delivery, 2021- 2031F |
6.1.5 Vietnam RNAI Therapeutics Market Revenues & Volume, By Intravenous Injections, 2021- 2031F |
6.1.6 Vietnam RNAI Therapeutics Market Revenues & Volume, By Intraperitoneal Injections, 2021- 2031F |
6.1.7 Vietnam RNAI Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam RNAI Therapeutics Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Vietnam RNAI Therapeutics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.2.3 Vietnam RNAI Therapeutics Market Revenues & Volume, By Research and Academic Laboratories, 2021- 2031F |
6.2.4 Vietnam RNAI Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
7 Vietnam RNAI Therapeutics Market Import-Export Trade Statistics |
7.1 Vietnam RNAI Therapeutics Market Export to Major Countries |
7.2 Vietnam RNAI Therapeutics Market Imports from Major Countries |
8 Vietnam RNAI Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for RNAi therapeutics in Vietnam |
8.2 Adoption rate of RNAi therapeutics by healthcare providers in Vietnam |
8.3 Number of partnerships and collaborations between local and international pharmaceutical companies for RNAi therapeutics in Vietnam. |
9 Vietnam RNAI Therapeutics Market - Opportunity Assessment |
9.1 Vietnam RNAI Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Vietnam RNAI Therapeutics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Vietnam RNAI Therapeutics Market - Competitive Landscape |
10.1 Vietnam RNAI Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Vietnam RNAI Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here